Steven Gershon, MD
Pain Medicine · Virginia Beach, VANPI 1073541736
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (41.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 59 manufacturers reported payments, led by AbbVie at 45.7% of the total. Reporting peaked in 2023 at $36,761 and has fallen 70.2% since, to $10,963 in 2025. Among pain medicine clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 548 payments — averaging $142.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$36K
- Kowa Pharmaceuticals America, Inc.$24K
- Vertex$9K
- Nevro Corp.$825
- Lundbeck LLC$658
- Pfizer$613
- plus $7K from 53 others
Across 51 payments — averaging $10,172 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Seikagaku Corporation$509K
- Eli Lilly$10K
What the payments were for
- Consulting fees$31,29040%
- Speaking & faculty fees$32,43842%
- Travel & lodging$1,5702%
- Food & beverage$12,77216%
- Education$70%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$28,168
- Seglentis$24,197
- QULIPTA$21,038
- JOURNAVX$8,121
- BARRICAID ACD (ANNULAR CLOSURE DEVICE)$336
- WaveWriter Alpha Prime 16$241
- Omnia$169
- Senza Spinal Cord Stimulation System$125
- VYEPTI$125
- Leqembi$121
- AIMOVIG$118
- Stimrouter Implantable Kit$118
- NURTEC ODT$117
- NUEDEXTA$115
- VIPER$114
- CONCORDE$114
- CONDUIT$114
- INTELLIS$111
How this compares
$78,076 in reported general payments places this provider in the 95th percentile of 150 pain medicine providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $292 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 12 | $199 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Virginia Beach
- Victor TsengVirginia Beach$13K
- Robert SpearVirginia Beach$4K
- Chheany UngRoanoke$198K
- Daniel KendallMc Lean$100K
- Jared DavisFishersville$45K
- Nameer HaiderWoodbridge$36K
- Lynn KohanCharlottesville$30K
- George BaylorSalem$24K
- Jasmit BrarLansdowne$18K
- Christina ShinCharlottesville$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.